REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/03/2026
Voltar para busca
Dado oficial do USPTO
Z
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
31/03/2026
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
29/07/2019
Data de registro
30/03/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/03/2021
Última transação
31/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
AU
Examinador
STRUCK, ROBERT J
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a stylized letter "Z" inside of a circle.
Titulares e representantes
Titulares
ZELIRA THERAPEUTICS LIMITED
Representantes
Elizabeth M. O'Donoghue Stradley Ronon Stevens & Young, LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Preparations for medical purposes derived from cannabis for the preventionmanagement and treatment of opioid addictioncancer including breast cancerbrain cancer and pancreatic cancerpainchronic painterminal illnessesepilepsyarthritiscrohn's diseaseinsomniadiabeteseczemapsychiatric diseases and disorders including mood disordersanxiety disorderssleep disorderscognitive disordersAlzheimer'sdepressionautism and post-traumatic stress disorder; all of the foregoing containing or solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
Classe 42
Conducting clinical trials for others; research relating to science; provision of pharmaceutical research services; project management and planning of clinical trialsconsulting services for others in the field of designplanningimplementation project management of clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; scientific research relating to medicinal use of cannabis; scientific research and development of medicinal cannabis products; medical research; scientific research for medical purposes; scientific research; all of the foregoing featuring only hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/07/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/07/2021
FIMP
FINAL DISPOSITION PROCESSED
01/07/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
30/03/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/03/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/02/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
17/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2021
PUBO
PUBLISHED FOR OPPOSITION
12/01/2021
GPNX
NOTIFICATION PROCESSED BY IB
10/01/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/01/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/12/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
30/11/2020
ALIE
ASSIGNED TO LIE
30/11/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30/11/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
30/11/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/11/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/11/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/11/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/11/2020
RFNT
REFUSAL PROCESSED BY IB
26/09/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/09/2020
RFRR
REFUSAL PROCESSED BY MPU
01/09/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/08/2020
CNRT
NON-FINAL ACTION WRITTEN
04/08/2020
DOCK
ASSIGNED TO EXAMINER
04/08/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
22/05/2020
DOCK
ASSIGNED TO EXAMINER
05/10/2019
MAFR
APPLICATION FILING RECEIPT MAILED
20/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/09/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace Z ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.